OraSure Technologies, Inc.
(NASDAQ : OSUR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories 2.49%103.430.8%$756.63m
TMOThermo Fisher Scientific, Inc. 1.02%422.411.0%$622.86m
ISRGIntuitive Surgical, Inc. 2.46%673.732.4%$492.93m
MDTMedtronic Plc 1.90%103.190.6%$481.51m
DHRDanaher Corp. 1.81%207.180.7%$449.88m
BDXBecton, Dickinson & Co. 1.35%224.151.0%$422.13m
INOInovio Pharmaceuticals, Inc. 10.22%16.945.9%$416.15m
QDELQuidel Corp. 2.51%196.777.7%$403.46m
DXCMDexCom, Inc. 5.32%402.367.9%$319.09m
SYKStryker Corp. 2.90%204.731.3%$282.17m
BSXBoston Scientific Corp. 0.59%37.341.0%$281.37m
VARVarian Medical Systems, Inc. 0.07%171.989.1%$257.67m
BAXBaxter International, Inc. 1.20%79.651.8%$246.33m
ALGNAlign Technology, Inc. 1.94%317.936.4%$227.19m
EWEdwards Lifesciences Corp. 3.74%77.460.4%$226.03m

Company Profile

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.